ISSN: 2161-0681
Journal of Clinical & Experimental Pathology
黑料网
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 2975
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- Cosmos IF
- Ulrich's Periodicals Directory
- RefSeek
- Directory of Research Journal Indexing (DRJI)
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
- world cat
- journal seek genamics
- j-gate
- esji (eurasian scientific journal index)
Useful Links
Recommended Journals
Related Subjects
Share This Page
Increased presence of the sphingolipid pathway in Alzheimer芒�?�?s disease with capillary cerebral amyloid angiopathy
7th World Congress on Molecular Pathology
Hripsime Snkhchyan
VU Medical Center, Netherlands
Posters & Accepted Abstracts: J Clin Exp Pathol
DOI:
Abstract
Cerebral amyloid angiopathy (CAA) is frequently observed in Alzheimer芒�?�?s disease (AD) and is marked by deposition of amyloid beta (A�?虏) in leptomeningeal and cortical brain vasculature. In over 40% of AD cases, A�?虏 accumulates in cortical capillaries, a phenomenon referred to as capillary CAA (capCAA), which is associated with loss of tight junction proteins and a reduced function of P-glycoprotein, indicating impaired function of the blood brain barrier (BBB) and decreased transport of amyloid beta across the BBB. Increasing evidence suggests that an altered sphingolipid (SL) metabolism contributes to Alzheimer's disease. However, to date it remains unknown if alteration of the SL pathway is involved in capCAA pathogenesis. In this study we set out to investigate the alterations of the different players of the SL pathway in capCAA. Expression and localization of ceramide, sphingosine-1-phosphate (S1P) receptors (S1P1, S1P3) and the enzyme involved in ceramide production, acid sphingomyelinase (ASM), were assessed using immunohistochemistry on post-mortem tissue from the occipital cortex of non-neurological controls, AD and severe capCAA cases. Increased immunoreactivity for ceramide, S1P3, S1P1 and ASM was observed in capCAA cases compared to non-neurological controls and AD cases. Immunoreactivity for ceramide and S1P3 was primarily observed in astrocytes, whereas immunoreactivity for S1P1 and ASM was observed in microglia. In capCAA, all SL markers showed high levels of immunoreactivity around amyloidladen capillaries and correlated with the presence GFAP and HLA-DR as markers for glial activation. We find increased presence of SL pathway markers in AD cases with capCAA. The increased presence of these markers in glial cells associated amyloid-laden capillaries, suggests that the SL pathway is involved in the neuroinflammatory response in capCAA pathogenesis. Future studies are needed to address the functional role of the SL pathway in capCAA pathology.Biography
Email: hripsimesnkhchyan@yandex.com
